TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3029% below fair value
$93.91+1.70 (+1.84%)
Close on Nov 17, 2026Market cap $3.26BP/E 24.4Yield 0.00%
TransMedics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
TransMedics's operating cash flow for the twelve months ending Jun 30, 2026 was $145.93M, up 26.6% year over year. For fiscal 2025 it was $192.84M, up 295.1% from the year before. The highest annual figure on record is $192.84M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $192.84M | +295.1% |
| FY2024 | Dec 31, 2024 | $48.80M | – |
| FY2023 | Dec 31, 2023 | -$13.03M | – |
| FY2022 | Dec 31, 2022 | -$45.82M | – |
| FY2021 | Dec 31, 2021 | -$28.86M | – |
| FY2020 | Dec 31, 2020 | -$30.27M | – |
| FY2019 | Dec 28, 2019 | -$32.29M | – |
| FY2018 | Dec 29, 2018 | -$25.98M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $17.31M | -81.1% |
| Q1 FY2026 | Mar 31, 2026 | $24.53M | – |
| Q4 FY2025 | Dec 31, 2025 | $34.51M | +75.5% |
| Q3 FY2025 | Sep 30, 2025 | $69.57M | +914.6% |
| Q2 FY2025 | Jun 30, 2025 | $91.61M | +256.2% |
| Q1 FY2025 | Mar 31, 2025 | -$2.86M | – |
| Q4 FY2024 | Dec 31, 2024 | $19.66M | +136.8% |
| Q3 FY2024 | Sep 30, 2024 | $6.86M | – |
| Q2 FY2024 | Jun 30, 2024 | $25.72M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.44M | – |
| Q4 FY2023 | Dec 31, 2023 | $8.30M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.87M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.80M | – |
| Q1 FY2023 | Mar 31, 2023 | -$8.66M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.04M | – |
| Q3 FY2022 | Sep 30, 2022 | -$14.28M | – |
| Q2 FY2022 | Jun 30, 2022 | -$9.09M | – |
| Q1 FY2022 | Mar 31, 2022 | -$18.41M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.65M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.35M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.54M | – |
| Q1 FY2021 | Mar 31, 2021 | -$7.33M | – |
| Q4 FY2020 | Dec 31, 2020 | -$7.14M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.41M | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.54M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.18M | – |
| Q4 FY2019 | Dec 28, 2019 | -$7.26M | – |
| Q3 FY2019 | Sep 28, 2019 | -$5.60M | – |
| Q2 FY2019 | Jun 29, 2019 | -$12.16M | – |
| Q1 FY2019 | Mar 30, 2019 | -$7.27M | – |
| Q4 FY2018 | Dec 29, 2018 | -$6.12M | – |
| Q3 FY2018 | Sep 29, 2018 | -$6.06M | – |
| Q2 FY2018 | Jun 30, 2018 | -$7.47M | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.33M | – |
See a number that looks wrong?